Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessing Communication Impairments in a Rare Neurodevelopmental Disorder: The SCN2A Clinical Trials Readiness Study. | Neurol Clin Pract | 2025 | 39439575 | PubTator, text mining | PubMed |
| Correction to: Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders. | Brain | 2025 | 39271170 | PubTator, text mining | PubMed |
| Visual and auditory attention in individuals with DYRK1A and SCN2A disruptive variants. | Autism Res | 2025 | 39080977 | PubTator, text mining | PubMed |
| Nav1.2 channel mutations preventing fast inactivation lead to SCN2A encephalopathy. | Brain | 2025 | 38939966 | PubTator, text mining | PubMed |
| Investigating the increased risk of schizophrenia and bipolar disorders in relatives of ADHD probands using colocalization analysis of common genetic variants. | Eur Child Adolesc Psychiatry | 2025 | 38836921 | PubTator, text mining | PubMed |
| Gene therapy as an emerging treatment for Scn2a mutation-induced autism spectrum disorders. | Fundam Res | 2024 | 39734530 | PubTator, text mining | PubMed |
| Improvement of variant reclassification in genetic neurodevelopmental conditions. | Genet Med Open | 2024 | 39669614 | PubTator, text mining | PubMed |
| National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy. | J Med Genet | 2024 | 39613335 | PubTator, text mining | PubMed |
| Cortical Vision Impairment (CVI)-informed assessment and treatment of challenging behavior in a child with SCN2A-related disorder. | J Neurodev Disord | 2024 | 39609790 | PubTator, text mining | PubMed |
| Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction. | ArXiv | 2024 | 39606727 | PubTator, text mining | PubMed |
| Uncovering causal gene-tissue pairs and variants: A multivariable TWAS method controlling for infinitesimal effects. | medRxiv | 2024 | 39606410 | PubTator, text mining | PubMed |
| Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells. | Viruses | 2024 | 39599840 | PubTator, text mining | PubMed |
| Two Novel Variants in the CHRNA2 and SCN2A Genes in Italian Patients with Febrile Seizures. | Genes (Basel) | 2024 | 39596607 | PubTator, text mining | PubMed |
| A sexually dimorphic signature of activity-dependent BDNF signaling on the intrinsic excitability of pyramidal neurons in the prefrontal cortex. | Front Cell Neurosci | 2024 | 39569070 | PubTator, text mining | PubMed |
| A patient organization perspective: charting the course to a cure for SCN2A-related disorders. | Ther Adv Rare Dis | 2024 | 39533986 | PubTator, text mining | PubMed |
| Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies. | Cells | 2024 | 39513870 | PubTator, text mining | PubMed |
| Epidemiologic profile of hemoglobinopathies in Benin. | Hematol Transfus Cell Ther | 2024 | 39426879 | PubTator, text mining | PubMed |
| [Contribution of the Ibero-American Academy of Neuropediatrics to the knowledge of self-limited epilepsy in infants]. | Medicina (B Aires) | 2024 | 39331768 | PubTator, text mining | PubMed |
| Genotype-driven therapeutics in DEE and metabolic epilepsy: navigating treatment efficacy and drug resistance. | Sci Rep | 2024 | 39285222 | PubTator, text mining | PubMed |
| Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing. | Front Genet | 2024 | 39280100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=11